A 46-year-old attorney from Columbus walks into my office and tells me she could not remember a co-worker's name in a meeting last week, and that she had to stare at a brief for two minutes before the legal argument she was reading made sense. She has been in this profession for 20 years. She is not slowing down, she tells me. She is forgetting. Her primary care provider ran a TSH that came back at 3.1 and told her everything looked fine. She is afraid of what is happening, and she is afraid that nobody is going to take it seriously.
This is one of the conversations I have most often, and it is one of the most important. Memory and cognitive symptoms in the 40s and 50s are dismissed routinely as "stress" or "perimenopause" or "just getting older," and a meaningful percentage of those patients have a treatable underlying contributor that nobody bothered to look for. Not every memory complaint is a treatable one. But the only way to distinguish the treatable from the not-treatable is the actual workup, and the actual workup is rarely what these patients have had.
I take cognitive symptoms in mid-life seriously because the brain is exquisitely sensitive to hormonal, metabolic, vascular, and inflammatory inputs, and a small shift in any of those domains produces a real and measurable cognitive change.
What is actually happening when memory shifts in mid-life
The brain runs on glucose, oxygen, and an intact hormonal signaling environment. Cognitive function depends on intact synaptic transmission, sufficient cerebral blood flow, controlled inflammation, balanced neurotransmitter availability, and the trophic effects of estrogen, testosterone, and thyroid hormone on neuronal health. A meaningful disruption in any of those produces a felt clinical symptom, and mid-life is the window in which several of those systems shift simultaneously.
Estrogen withdrawal. Estrogen is neuroprotective. It modulates synaptic plasticity, cerebral blood flow, glucose uptake in the brain, and serotonergic and dopaminergic transmission. The decline of estrogen in perimenopause and menopause produces the classic cognitive symptom cluster — word-finding difficulty, working memory changes, slowed processing — that I see in women in their 40s and 50s. This is real physiology, not a perception problem.
Testosterone decline. Testosterone supports cognitive function in both sexes. It modulates dopamine, supports cerebral perfusion, and has independent effects on motivation, focus, and mental endurance. Men with testosterone deficiency frequently report cognitive symptoms before they recognize the libido or energy changes.
Thyroid dysfunction. Subclinical hypothyroidism — TSH in the 2.5 to 4.5 range that conventional reference ranges call "normal" — produces clinically meaningful cognitive symptoms. The optimal TSH for cognitive function is generally below 2.0. Free T3 matters more than TSH for what the brain is actually receiving. A patient with a TSH of 3.1, low-normal free T4, and low free T3 is hypothyroid at the tissue level even when the standard panel says she is not.
Insulin resistance and metabolic dysfunction. The brain is an insulin-sensitive organ. Impaired insulin signaling in neurons reduces glucose uptake and produces the brain fog and slowed processing that insulin-resistant patients describe. Fasting insulin above 10 mIU/L with normal fasting glucose is a finding that explains cognitive symptoms in the absence of any other identifiable contributor.
Sleep architecture disruption. Memory consolidation happens during slow-wave and REM sleep. Patients with disrupted sleep — from progesterone deficiency, vasomotor symptoms, sleep apnea, or stress-related insomnia — accumulate cognitive deficit faster than the sleep loss alone would predict.
Nutritional contributors. B12 deficiency (particularly common in patients on metformin or PPIs), vitamin D deficiency, iron deficiency without anemia, and magnesium insufficiency all produce cognitive symptoms before they produce the classic clinical syndromes most providers screen for.
Medication side effects. Statins, beta-blockers, anticholinergics, benzodiazepines, certain antidepressants, and older sleep aids contribute to cognitive symptoms in mid-life patients more than the prescribing provider usually acknowledges.
In most patients I evaluate, the cognitive picture is multifactorial — usually two to four of these contributors operating simultaneously. Addressing one in isolation produces a partial response. Addressing the cluster produces the kind of change patients tell me they had stopped expecting.
How I evaluate someone for cognitive change
The intake is detailed and the lab panel is broad. For a patient presenting with cognitive symptoms in mid-life, the workup I run includes:
- Full sex hormone panel: estradiol, progesterone, total and free testosterone, DHEA-S, SHBG, FSH, LH
- Complete thyroid panel: TSH, free T3, free T4, reverse T3, thyroid peroxidase antibodies, thyroglobulin antibodies
- Metabolic panel: fasting insulin, HbA1c, fasting glucose, lipid panel with apolipoprotein B if indicated
- Inflammatory and nutritional markers: hs-CRP, homocysteine, ferritin, vitamin D, vitamin B12, methylmalonic acid (more sensitive than B12 alone), magnesium, zinc
- Where indicated: cortisol pattern, ApoE genotyping for risk stratification, sleep study referral
I do not run every possible test on every patient. I run the panel that fits the presenting picture, and I review it personally with the patient at a follow-up visit so we are working from the same data.
The other piece of the workup I take seriously is the medication and supplement list. I want to know everything you take, including over-the-counter sleep aids, antihistamines, and supplements. The number of patients whose primary cognitive contributor turned out to be a medication started years ago for something unrelated is higher than most providers would guess.
What I look for first when results come back
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
When I review labs with a patient presenting with cognitive symptoms, I am looking for a coherent pattern, not a single abnormal value. A few patterns I see repeatedly:
The perimenopausal pattern: estradiol fluctuating, progesterone low, free testosterone in the bottom decile, FSH starting to climb, with a TSH in the suboptimal range and a fasting insulin creeping up. This patient has 4 contributors operating at once, and addressing only the FSH-defined "menopause" piece misses most of what is producing her symptoms.
The metabolic-cognitive pattern: fasting insulin of 14, HbA1c at 5.7, triglyceride-to-HDL ratio above 2, often with low-normal vitamin D and elevated hs-CRP. These patients are insulin-resistant with neuroinflammatory overlay, and the cognitive symptoms respond to metabolic intervention — sometimes including GLP-1 therapy — more than they respond to anything aimed directly at the brain.
The under-treated thyroid pattern: TSH between 2.5 and 4.5, low-normal free T4, low free T3, sometimes elevated antibodies. These patients have been told they are "normal" for years and have been quietly hypothyroid the entire time.
The medication-driven pattern: a patient on a combination of beta-blocker, statin, low-dose benzodiazepine, and antihistamine who has progressively shifted into cognitive symptoms over the last 2 to 3 years. The right move is a coordinated medication review with the prescribing providers before any other intervention.
What treatment looks like in practice
Treatment depends entirely on what the workup identifies. The interventions I use most frequently include:
Hormone optimization for women with documented sex hormone deficiency and perimenopausal cognitive symptoms. Bioidentical estradiol and progesterone restore the trophic environment the brain depends on, and physiologic testosterone supplementation addresses the energy, focus, and motivation piece that estrogen and progesterone alone do not cover.
Men's hormone therapy for male patients with testosterone deficiency contributing to cognitive symptoms. Restoration of testosterone to mid-normal range typically produces noticeable cognitive improvement within 4 to 8 weeks.
Metabolic program for patients with insulin resistance as a primary cognitive driver. This includes dietary structure, resistance training, and where appropriate GLP-1 therapy. The cognitive benefit of treating insulin resistance is consistently underappreciated.
Targeted nutritional repletion for documented deficiencies — B12 with methylmalonic acid follow-up, vitamin D titrated to a target of 50 to 80 ng/mL, ferritin above 70, magnesium repletion when low.
Thyroid optimization that targets free T3 and free T4 in the upper half of the reference range rather than treating to the TSH alone, in coordination with the patient's endocrinology provider when appropriate.
Medication review with the prescribing providers for any contributors on the medication list.
Sleep evaluation referral when the architecture is disrupted in a way that the workup suggests is the primary driver.
Realistic timeline
Acute interventions like B12 repletion or stopping a contributing medication produce noticeable cognitive change within 2 to 4 weeks. Hormone optimization typically produces initial response at 2 to 4 weeks and full effect at 3 to 6 months. Metabolic interventions produce early markers of change at 4 to 8 weeks and sustained cognitive change at 3 to 6 months as insulin signaling improves and visceral fat reduces. Thyroid corrections vary by how far from optimal the patient started.
I track response with structured symptom inventories at every reassessment so we have data, not impressions. Patients who engage with the reassessment cycle produce better outcomes than patients who stop checking in once they feel better.
Your concrete next step
If memory and cognitive symptoms have been bothering you for more than three months, or if they are affecting your work or your relationships, the next step is a real workup, not another reassurance that it is "just stress." Take 10 minutes with the symptom assessment tool so you arrive with an organized picture, then book comprehensive lab work and a 45-minute clinical intake at the Columbus consultation office or the Warner Robins consultation. The first visit is the history and the lab order; the second visit, two to three weeks later, is the lab review and the treatment plan. By the end of that second visit you should know what is contributing to your symptoms and what the path forward looks like. That is the gap that needs to close, and it is closeable.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.